Abstract:Recent efforts for increasing the success in drug discovery focus on an early, massive, and routine mechanistic and/or kinetic characterization of drug-target engagement as part of a design-make-test-analyze strategy. From an experimental perspective, many mechanistic assays can be translated into a scalable format on automation platforms and thereby enable routine characterization of hundreds or thousands of compounds. However, now the limiting factor to achieve such in-depth characterization at high-throughput becomes the quality-driven data analysis, the sheer scale of which outweighs the time available to the scientific staff of most labs. Therefore, automated analytical workflows are needed to enable such experimental scale-up. We have implemented such a fully automated workflow in Genedata Screener for time-dependent ligand-target binding analysis to characterize non-equilibrium inhibitors. The workflow automates Quality Control (QC) / data modelling and decision-making process in a staged analysis: (1) quality control of raw input data-fluorescence signal-based progress curves - featuring automated rejection of unsuitable measurements; (2) automated model selection - one-step versus two-step binding model - using statistical methods and biological validity rules; (3) result visualization in specific plots and annotated result tables, enabling the scientist to review large result sets efficiently and, at the same time, to rapidly identify and focus on interesting or unusual results; (4) an interactive user interface for immediate adjustment of automated decisions, where necessary. Applying this workflow to first-pass, high-throughput kinetic studies on kinase projects has allowed us to surmount previously rate-limiting manual analysis steps and boost productivity; and is now routinely embedded in a biopharma discovery research process.

Direct Assembling Methodologies for High‐throughput Bioscreening

Ultrahigh-Throughput Enzyme Engineering and Discovery in In Vitro Compartments

Microengineering Methods for Cell-Based Microarrays and High-Throughput Drug-Screening Applications

A Sandwiched Microarray Platform for Benchtop Cell-Based High Throughput Screening

Completing the Screen: Biochemical Cascades to Prioritize HTS Output

Rapid Buildup Arrays with Orthogonal Biochemistry Gradients Via Light-Induced Thiol-Ene "click" Chemistry for High-Throughput Screening of Peptide Combinations

High-throughput screening for improving cellular and enzymatic properties

Autonomous high-throughput screening technology for accelerating drug molecule discovery and synthesis

High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery

High-throughput Screening Based on Small-Molecule Microarrays and OI-RD Microscope

NanoStore: A Concept for Logistical Improvements of Compound Handling in High-Throughput Screening

Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening

Combinatorial High-Throughput Screening of Complex Polymeric Enzyme Immobilization Supports

High-Throughput Screening Based on Label-Free Detection of Smallmolecule Microarrays

High throughput miniature drug-screening platform using bioprinting technology

State-of-the-art in high throughput organ-on-chip for biotechnology and pharmaceuticals

The latest advances in high content screening in microfluidic devices

High Throughput, Label-free Screening Small Molecule Compound Libraries for Protein-Ligands Using Combination of Small Molecule Microarrays and a Special Ellipsometry-based Optical Scanner.

High-throughput screening of biomolecules using cell-free gene expression systems

Current progress in high-throughput screening for drug repurposing

Compartmentalization of Enhanced Biomolecular Interactions for High-Throughput Drug Screening in Test Tubes